Related Content
February 24, 2021 — Occlutech announced the completion of patient enrollment in the PRELIEVE trial, pilot study to ...
February 24, 2021
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...
January 27, 2021
Feature | Heart Valve Technology| Dave Fornell
Off-label use of the St. Jude Amplatzer vascular plug devices offers a new solution for the minimally invasive repair of ...
February 08, 2016
October 7, 2014 — Occlutech announced that it has obtained a European CE mark approval for its dedicated Paravalvular ...
October 07, 2014August 1, 2014 — Occlutech announced that it has successfully obtained a ruling by the U.K. Patents Court in the High ...
August 01, 2014
May 31, 2012 — Occlutech GmbH, a European developer of minimally invasive implants for the treatment of structural heart ...
May 31, 2012September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court in ...
September 27, 2011
August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro ...
August 25, 2011
May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the ...
May 16, 2011
June 28, 2010 – AGA Medical has been denied the right to appeal a decision in a United Kingdom patent case concerning ...
June 27, 2010